University Hospital Hamburg-Eppendorf is planning to build a 193,000-sf translational medicine hub in Hamburg, Germany. Housing the Campus Research II facility and the Hamburg Center for Translational Immunology, the interdisciplinary complex will provide 150 labs for the study of inflammation, infection, and immunology. The structure will also accommodate collaborative workspaces, instrumentation suites, research offices, and interaction zones. Supported by $51.5 million in funding from the German government and the City of Hamburg, the project will be developed by Klinik Facility-Management Eppendorf and leased by the hospital under a tenant-landlord model, with the city subsidizing the rent. Construction is expected to begin by early 2021 with completion slated for 2023.